The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world clinical outcomes with standard dose (SD) and reduced dose (RD) trastuzumab deruxtecan (TDxD) in metastatic HER2-positive and HER2-low breast cancer.
 
Jasskiran Kaur
No Relationships to Disclose
 
Nickolas Stabellini
No Relationships to Disclose
 
Naji Mallat
No Relationships to Disclose
 
Takae Mizukami
No Relationships to Disclose
 
Bahar Moftakhar
No Relationships to Disclose
 
Cynthia Owusu
No Relationships to Disclose
 
Alberto Montero
Honoraria - AstraZeneca; Celgene; OncoSec
Consulting or Advisory Role - New Century Health; Paragon healthcare; Welwaze
Research Funding - F. Hoffmann-La Roche Ltd, Basel, Switzerland
(OPTIONAL) Uncompensated Relationships - Roche